AVORO CAPITAL ADVISORS LLC – Alnylam Pharmaceuticals, Inc. Transaction History
AVORO CAPITAL ADVISORS LLC portfolio value:
$221.17M
portfolio value
AVORO CAPITAL ADVISORS LLC quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -18.75% | -255K shares | 22.82M | $200.16 | 1.10M |
| Q2 2022 | share | Increase | +4.62% | 60K shares | -13.92M | $145.85 | 1.36M |
| Q1 2022 | share | Increase | +20.93% | 225K shares | 29.97M | $163.29 | 1.3M |
| Q4 2021 | share | Increase | +26.47% | 225K shares | 21.81M | $171.03 | 1.07M |
| Q3 2021 | call | Decrease | -100.00% | -150K shares | -1.42M | $188.81 | 0 |
| Q3 2021 | share | Decrease | -15.00% | -150K shares | -9.03M | $188.81 | 850K |
| Q2 2021 | share | Increase | 0.00% | 1M shares | 169.52M | $169.52 | 1M |
| Q2 2021 | call | Increase | 0.00% | 150K shares | 1.42M | $169.52 | 150K |
| Q3 2018 | share | Decrease | -100.00% | -700.1K shares | -68.95M | $87.52 | 0 |
| Q2 2018 | share | Increase | 0.00% | 700.1K shares | 68.95M | $98.49 | 700.1K |